Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CTO Realty Growth A Pref | CTO-A | Oct 11, 2024 | 24.65 | +2.11 |
CTS | CTS | Oct 11, 2024 | 48.25 | +1.64 |
CubeSmart | CUBE | Oct 11, 2024 | 49.82 | -0.18 |
Cue Biopharma | CUE | Oct 11, 2024 | 1.23 | -7.52 |
Cullen Frost Bankers B Pref | CFR-B | Oct 11, 2024 | 21.34 | +0.52 |
Cullen/Frost Bankers | CFR | Oct 11, 2024 | 118.80 | +2.57 |
Cullinan Therapeutics | CGEM | Oct 11, 2024 | 16.22 | +2.21 |
Cullman Bancorp | CULL | Oct 11, 2024 | 9.71 | 0.00 |
Culp | CULP | Oct 11, 2024 | 5.94 | +1.71 |
Cumberland Pharmaceuticals | CPIX | Oct 11, 2024 | 1.31 | +2.34 |
Cummins | CMI | Oct 11, 2024 | 336.07 | +0.97 |
Cumulus Media A | CMLS | Oct 11, 2024 | 1.36 | +4.62 |
Curbline Properties Corp. When Issued | CURB | Oct 11, 2024 | 23.65 | 0.00 |
Curevac N.V. | CVAC | Oct 11, 2024 | 2.91 | +1.39 |
CuriosityStream | CURI | Oct 11, 2024 | 2.11 | -4.52 |
Curis | CRIS | Oct 11, 2024 | 5.30 | +2.12 |
CURRENC Group | CURR | Oct 11, 2024 | 1.95 | 0.00 |
Curtiss-Wright | CW | Oct 11, 2024 | 346.92 | +1.95 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Oct 11, 2024 | 45.50 | -3.60 |
Cushman & Wakefield | CWK | Oct 11, 2024 | 12.53 | +1.54 |
Custom Truck One Source | CTOS | Oct 11, 2024 | 3.42 | +8.57 |
Customers Bancorp | CUBI | Oct 11, 2024 | 47.33 | +4.83 |
Customers Bancorp E Pref | CUBI-E | Oct 11, 2024 | 25.42 | -0.50 |
Customers Bancorp F Pref | CUBI-F | Oct 11, 2024 | 25.24 | -0.04 |
Cutera | CUTR | Oct 11, 2024 | 0.76 | +3.98 |
CVB Financial | CVBF | Oct 11, 2024 | 18.81 | +4.67 |
CVD Equipment | CVV | Oct 11, 2024 | 3.27 | +0.74 |
CVR Energy | CVI | Oct 11, 2024 | 24.79 | +0.65 |
Cvr Partners LP Unit | UAN | Oct 11, 2024 | 71.07 | +3.03 |
CVRx | CVRX | Oct 11, 2024 | 7.48 | +7.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.